Kenvue Inc. (NYSE:KVUE) Shares Sold by TBH Global Asset Management LLC

TBH Global Asset Management LLC decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 11.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,820 shares of the company’s stock after selling 7,883 shares during the quarter. TBH Global Asset Management LLC’s holdings in Kenvue were worth $1,266,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Team Hewins LLC acquired a new position in shares of Kenvue during the 4th quarter valued at $405,000. TCW Group Inc. increased its stake in Kenvue by 76.5% during the 4th quarter. TCW Group Inc. now owns 560,386 shares of the company’s stock worth $12,065,000 after buying an additional 242,923 shares during the period. SageView Advisory Group LLC purchased a new stake in Kenvue during the 4th quarter worth $262,000. US Bancorp DE increased its stake in Kenvue by 111.7% during the 4th quarter. US Bancorp DE now owns 103,733 shares of the company’s stock worth $2,233,000 after buying an additional 54,729 shares during the period. Finally, Ontario Teachers Pension Plan Board purchased a new stake in Kenvue during the 4th quarter worth $2,001,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on KVUE shares. JPMorgan Chase & Co. dropped their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research report on Friday, February 9th. William Blair started coverage on shares of Kenvue in a report on Wednesday, April 3rd. They issued a “market perform” rating for the company. The Goldman Sachs Group started coverage on shares of Kenvue in a report on Friday, March 1st. They issued a “neutral” rating and a $20.00 price target for the company. Royal Bank of Canada decreased their price target on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 9th. Finally, HSBC lifted their price target on shares of Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a report on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $24.38.

Kenvue Price Performance

Shares of NYSE:KVUE traded down $0.09 during trading on Friday, reaching $19.35. The company had a trading volume of 24,294,091 shares, compared to its average volume of 18,820,695. The firm’s fifty day moving average is $20.01 and its 200 day moving average is $20.20. The firm has a market capitalization of $37.05 billion and a PE ratio of 24.92. Kenvue Inc. has a twelve month low of $17.82 and a twelve month high of $26.74. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.99.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $3.79 billion. Kenvue’s quarterly revenue was down 24.9% on a year-over-year basis. On average, equities analysts forecast that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Tuesday, May 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.13%. Kenvue’s dividend payout ratio is currently 102.56%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.